SEC Form 4 · accession 0001209191-18-057561
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip D Gregory
Officer — Chief Scientific Officer
Period of report
Nov 5, 2018
Accepted (ET)
Nov 7, 2018 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 5, 2018 | M | 600 | $50.51 | A | 31,971 | D | |
| Common Stock | Nov 5, 2018 | M | 700 | $75.60 | A | 32,671 | D | |
| Common StockF2 | Nov 5, 2018 | S | 600 | $136.49 | D | 32,071 | D | |
| Common StockF3 | Nov 5, 2018 | S | 948 | $137.6985 | D | 31,123 | D | |
| Common StockF4 | Nov 5, 2018 | S | 252 | $138.2735 | D | 30,871 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $50.51 | Nov 5, 2018 | M | 600 | D | — | Mar 1, 2026 | Common Stock | 600 | 14,600 | D |
| Stock Option (right to buy)F6 | $75.60 | Nov 5, 2018 | M | 700 | D | — | Feb 1, 2027 | Common Stock | 700 | 31,300 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- F2The range in prices for the transaction reported on this line was $135.91 to $136.88. The average weighted price was $136.49. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $137.16 to $138.15. The average weighted price was $137.6985. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $138.21 to $138.72. The average weighted price was $138.2735. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017 and in 36 equal monthly installments thereafter.
- F6This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2018 and in 36 equal monthly installments thereafter.